Cian Healthcare Limited (BOM:542678)
India · Delayed Price · Currency is INR 9.55
+0.45 (4.95%)
At close: Jul 14, 2026
Cian Healthcare Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue Revenue Growth | 232.8 | 308.54 | 618.92 | 686.76 | 780.66 | 739.41 |
Revenue Growth | -24.55% | -50.15% | -9.88% | -12.03% | 5.58% | 28.98% |
Gross Profit Gross Profit Growth | 17.05 | 78.36 | 305.4 | 345.88 | 294.16 | 330.46 |
Operating Income Operating Income Growth | -129.23 | -109.18 | 57.99 | 76.45 | 2.86 | 87.46 |
Net Income Net Income Growth | -130.49 | -259.78 | 8.49 | 20.3 | -55.34 | 0.53 |
Earnings Per Share EPS Growth | -5.22 | -10.39 | 0.34 | 0.81 | -2.21 | 0.02 |
EPS Growth | - | - | -58.09% | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
India India Growth | 298.3 | 590.11 | 817.46 | 744.44 | 705.47 |
Export Export Growth | 39.75 | 107.93 | 98.44 | 91.83 | 77.58 |
Unallocated Unallocated Growth | -30.06 | -81.08 | -230 | -57.57 | -45.75 |
Total Total Growth | 307.98 | 616.96 | 685.9 | 778.7 | 737.3 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Investments Cash & Investments Growth | 107.04 | 177.7 | 11.94 | 13.3 | 13.42 | 23.25 |
Total Debt Total Debt Growth | 549.73 | 549.88 | 556.91 | 608.15 | 630.49 | 707.31 |
Net Cash (Debt) Net Cash Growth | -442.69 | -372.17 | -544.97 | -594.85 | -617.07 | -684.06 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -17.72 | -14.89 | -21.80 | -23.80 | -24.69 | -25.77 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 89.81 | 207.52 | 117.64 | 48.41 | 85.78 | 59.33 |
Capital Expenditures CapEx Growth | -0.62 | -4.06 | -9.79 | -13.25 | -173.18 | -14.71 |
Free Cash Flow Free Cash Flow Growth | 89.19 | 203.46 | 107.85 | 35.16 | -87.4 | 44.62 |
Free Cash Flow Growth | -56.16% | 88.65% | 206.76% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Gross Margin | 7.32% | 25.40% | 49.34% | 50.36% | 37.68% | 44.69% |
Operating Margin | -55.51% | -35.39% | 9.37% | 11.13% | 0.37% | 11.83% |
Pretax Margin | -55.81% | -84.25% | 0.08% | 2.90% | -7.69% | 0.93% |
Profit Margin | -56.05% | -84.20% | 1.37% | 2.96% | -7.09% | 0.07% |
FCF Margin | 38.31% | 65.94% | 17.43% | 5.12% | -11.20% | 6.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | - | - | 60.88 | 34.49 | - | 494.93 |
P/FCF Ratio | 2.68 | 0.42 | 4.79 | 19.91 | - | 5.89 |
PS Ratio | 1.03 | 0.28 | 0.84 | 1.02 | 0.61 | 0.36 |